In this study, the network pharmacology analysis spectacled that CHKA may interact with the P13K/AKT pathway, which is abnormally active in various tumor cells and is closely related to tumor growth, proliferation, and metabolism (Hoxhaj and Manning, 2020). This evidence concerns the gene AKT1 and neoplasm.